PetVivo Holdings, Inc. (PETV)

Market Cap	17.01M
Revenue (ttm)	956.05K
Net Income (ttm)	-8.63M
Shares Out	24.29M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Average Volume	19,632
Open	0.6950
Previous Close	0.6950
Day's Range	0.6440 - 0.6955
52-Week Range	0.2904 - 0.9800
Beta	0.85
RSI	46.42
Earnings Date	Jun 27, 2025

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In 2023, PetVivo Holdings's revenue was $968,706, an increase of 5.62% compared to the previous year's $917,162. Losses were -$10.96 million, 25.7% more than in 2022.